Research & Publications
Dr. Joseph Kim is a board-certified medical oncologist and a Director of the Prostate Cancer Research Program for Prostate and Urological Cancers DART of Yale Cancer Center. He is a recipient of the Cancer Clinical Investigator Team Leadership Award from the National Cancer Institute (NCI) and a recipient of other awards from Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO). Dr. Kim has led several peer-reviewed, NCI-sponsored, investigator-initiated clinical trials in prostate cancer, bladder cancer, and other solid tumors as a study chair.
Dr. Joseph Kim serves as an author/editor of the genitourinary (GU) cancers chapter of ASCO-SEP, an educational textbook for medical oncologists, and a co-editor of the GU cancers section of a peer-reviewed journal, Current Oncology Report, and ad hoc reviewer of multiple oncology journals. He has been invited as a speaker for numerous international and national academic conferences including GU Cancers Symposium, ASCO Annual Meeting, CTEP/ NCI meeting, ASCO Direct highlights, International Genitourinary Cancer Conference, and many others.
His passion lies in delivering compassionate, patient-centered, and evidence-based care for patients with genitourinary cancer including prostate cancer, bladder, and other urinary tract cancer, testicular cancer, and penile cancer. He is also passionate about developing and executing hypothesis-driven clinical trials of novel therapies in GU cancers and other solid tumors.
Education & Training
- FellowNational Institutes of Health (2013)
- ResidentEmory University School of Medicine (2010)
- MDWake Forest University School of Medicine (2007)
Honors & Recognition
|Cancer Clinical Investigator Team Leadership Award (CCITLA)||NCI||2021|
|Young Investigator Award||Conquer Cancer Foundation, American Society of Clinical Oncology||2013|
|Merit Award||Conqer Cancer Foundation, American Society of Clinical Oncology||2013|
|ASCO-SEP||Editor||2021 - Present|
|Frontiers Oncology||Reviewer||2019 - Present|
|Current Oncology Reports||Editor||2015 - Present|
|American Association for Cancer Research||Member||2014 - Present|
|Society of Immunotherapy of Cancer||Member||2013 - Present|
|American Society of Clinical Oncology||Member||2010 - Present|